Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase 1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2Other hematologic neoplasm 2Lymphoid 2Classical hematology 2

Conditions

Anemia 27Neoplasms 9Multiple Myeloma 7Leukemia 7Lymphoma 6Breast Neoplasms 6Neoplasms, Plasma Cell 5Lymphoma, Non-Hodgkin 4Precancerous Conditions 3Lymphoma, Follicular 3Lung Neoplasms 3Leukemia, Lymphocytic, Chronic, B-Cell 3Hodgkin Disease 3Waldenstrom Macroglobulinemia 2Squamous Cell Carcinoma of Head and Neck 2Rectal Neoplasms 2Prostatic Neoplasms 2Myelodysplastic Syndromes 2Lymphoproliferative Disorders 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, B-Cell, Marginal Zone 2Head and Neck Neoplasms 2Drug-Related Side Effects and Adverse Reactions 2Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Sezary Syndrome 1

Interventions

Rituximab 23Cyclophosphamide 11Radiotherapy 8Prednisone 8Vincristine 7Doxorubicin 7Lenalidomide 6Bendamustine Hydrochloride 5Chlorambucil 4Peripheral Blood Stem Cell Transplantation 3Filgrastim 3obinutuzumab 2liposomal amphotericin B 2idelalisib 2ibrutinib 2fludarabine phosphate 2VAP-cyclo protocol 2Therapeutics 2Psychiatric Rehabilitation 2Levofloxacin 2Interferon-alpha 2Idarubicin 2Epoetin Alfa 2Early Intervention, Educational 2Cyclosporine 2Busulfan 2zanubrutinib 1tafasitamab 1parsaclisib 1orelabrutinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Lymphoma, B-Cell, Marginal Zone × Epoetin Alfa × Clear all
NCT00482716 2014-01-10

Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
80 enrolled
Classical hematologyLymphoidOther hematologic neoplasmPlasma cell

Anemia, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone, Neoplasms, Plasma Cell

NCT00003341 2013-07-03

Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy

Memorial Sloan Kettering Cancer Center

Phase 3 Completed
275 enrolled
Classical hematologyLymphoidOther hematologic neoplasmPlasma cell

Anemia, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡